Quarterly ResultMay 7, 2026, 06:22 AM
Rockwell Medical Q1 Net Sales $17.3M; Updates 2026 Guidance for Profitability
AI Summary
Rockwell Medical announced its first quarter 2026 financial results, reporting $17.3 million in net sales, an 8% decrease year-over-year, and a net loss of $1.6 million. Despite the sales decline, gross margin slightly improved to 17%. The company also provided updated 2026 guidance, emphasizing growth, improved gross margin, and generating positive cash flow, driven by operational changes expected to yield over $3 million in additional annualized gross profit and over $2 million in annualized savings.
Key Highlights
- Q1 2026 net sales were $17.3 million, an 8% decrease from Q1 2025.
- Q1 2026 gross profit was $2.9 million, in line with Q1 2025.
- Q1 2026 gross margin improved to 17% from 16% in Q1 2025.
- Q1 2026 net loss was $1.6 million, a slight increase from $1.5 million in Q1 2025.
- Operational changes are expected to generate over $3 million in additional annualized gross profit.
- Updated 2026 net sales guidance is $70.0 million to $75.0 million.
- Updated 2026 gross margin guidance is 18% to 22%.
- Updated 2026 Adjusted EBITDA guidance is $1.0 million to $2.0 million, with positive operating cash flow.